View Item 

Show simple item record

Possible Treatment of Parkinson's Disease with Intrathecal Medication in the MPTP Model
dc.contributor.authorHood, Terry W.en_US
dc.contributor.authorDomino, Edward F.en_US
dc.contributor.authorGreenberg, Harry S.en_US
dc.date.accessioned2010-06-01T20:49:02Z
dc.date.available2010-06-01T20:49:02Z
dc.date.issued1988-06en_US
dc.identifier.citationHOOD, TERRY W.; DOMINO, EDWARD F.; GREENBERG, HARRY S. (1988). "Possible Treatment of Parkinson's Disease with Intrathecal Medication in the MPTP Model." Annals of the New York Academy of Sciences 531(1 Neurological Applications of Implanted Drug Pumps ): 200-205. <http://hdl.handle.net/2027.42/73916>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73916
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3260087&dopt=citationen_US
dc.format.extent323592 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1988 The New York Academy of Sciencesen_US
dc.titlePossible Treatment of Parkinson's Disease with Intrathecal Medication in the MPTP Modelen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Surgery (Section of Neurosurgery), Pharmacology and Neurology University of Michigan Medical School Ann Arbor, Michigan 48109en_US
dc.identifier.pmid3260087en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73916/1/j.1749-6632.1988.tb31828.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1988.tb31828.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceHornkiewicz, O. 1966. Metabolism of brain dopamine in human parkinsonism: Neurochemical and clinical aspects. In Biochemistry and Pharmacology of the Basal Ganglia. E. Costa, L. J. Cote & M. D. Yahr, Eds. 171 – 181. Raven Press. New York, NY.en_US
dc.identifier.citedreferenceMarsden, C. D. & J. D. Parkes. 1976. “ On-off” effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1: 292 – 296.en_US
dc.identifier.citedreferenceMcDowell, F. H., J. E. Lee & R. D. Sweet. 1981. Extrapyramidal disease. In Clinical Neurology. A. B. Baker & L. H. Baker, Eds. Harper and Row. Philadelphia, PA.en_US
dc.identifier.citedreferenceRosin, A. J., D. Devereux, N. Eng & D. B. Calne. 1979. Parkinsonism with “on-off” phenomenonIntravenous treatment with levodopa after major abdominal surgery. Arch. Neurol. 36: 32 – 34.en_US
dc.identifier.citedreferenceObeso, J. A., M. R. Luquin & J. M. Martinez-Lage. 1986. Lisuride infusion pump: A device for the treatment of motor fluctuations in Parkinson's disease. Lancet 1: 467 – 470.en_US
dc.identifier.citedreferenceHargraves, R. W. & W. Freed. 1987. Chronic intrastriatal dopamine infusions reduce motor abnormalities in an animal model of Parkinson's disease. Presented at the Annual Meeting of the American Association of Neurological Surgeons. May 3–7. Dallas, TX.en_US
dc.identifier.citedreferenceLangston, J. W., P. Ballard, J. W. Tetrud & I. Irwin. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979 – 980.en_US
dc.identifier.citedreferenceBurns, R. S., C. C. Chiueh, S. P. Markey, M. H. Ebert, D. M. Jacobowitz & I. J. Kopin. 1983. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80: 4546 – 4550.en_US
dc.identifier.citedreferenceNutt, J. G., W. R. Woodward, J. P. Hammerstad, J. H. Carter & J. L. Anderson. 1984. The “on-off” phenomenon in Parkinson's diseaseRelation to levodopa absorption and transport. N. Engl. J. Med. 310: 483 – 488.en_US
dc.identifier.citedreferenceKlawans, H. L., C. Goetz, P. H. Nausieda & W. J. Weiner. 1977. Levodopa-induced dopamine receptor hypersensitivity. Ann. Neurol. 2: 125 – 129.en_US
dc.identifier.citedreferenceNutt, J. G., W. R. Woodward & J. H. Carter. 1986. Clinical and biochemical studies with controlled release Sinemet. Neurology 36: 1206 – 1211.en_US
dc.identifier.citedreferenceJuncos, J. L., G. Fabbrini, M. M. Mowradian, C. Serrati, A. M. Kask & T. N. Chase. 1987. Controlled release levodopa treatment of motor fluctuations in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 50: 194 – 198.en_US
dc.identifier.citedreferenceQuinn, N., C. D. Marsden & J. D. Parkes. 1982. Complicated response fluctuations in Parkinson's disease: Response to intravenous infusion of levodopa. Lancet 2: 412 – 415.en_US
dc.identifier.citedreferenceHood, T. W., E. F. Domino & H. S. Greenberg. 1987. Reversal of parkinsonism in the MPTP rhesus monkey model by intraventricular L-Dopa methyl ester. Presented at the Annual Meeting of the American Association of Neurological Surgeons. May 3–7. Dallas, TX.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1749-6632.1988.tb31828.x.pdf
Size:
316.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.